It’s akin to helping a flag football team bounce back from a blowout loss: You don’t retreat, you reframe—and build the ...

Scientists show how stem cells process DNA with speed and precision, revealing principles that could lead to programmable DNA ...

Makary announced plans for a new rare disease pathway in an April episode of "The Megyn Kelly Show." The proposal follows ...

From operational overhauls to product design, biomanufacturing and bioprocessing companies reduce their environmental impact.

What was once a problem of square footage is now a question of readiness. Only those who invest ahead of demand while staying lean and interoperable will be able to support the next wave of complex ...

The Golden Age of antibiotic discovery was characterized by remarkable openness and collaboration, and the same spirit is ...

The Food and Drug Administration today announced a plan to publicly release complete response letters at the same time they ...

The US biotechnology sector has been in a downturn since early 2022, with few signs of a rebound. The S&P Biotech ETF, or XBI ...

With superior reactivity and stability, nanocatalysts are transforming catalytic processes, driving advancements in green ...

Researchers at Hiroshima University (Japan) have introduced a new philosophical framework—"conditional bad-difference view" ...

FDA launches Rare Disease Evidence Principles to guide therapy reviews, offering new pathways for approval while raising ...

Looking to move up in the biotech world? There are lots of training programs out there that can help you get ahead. Whether ...